SCHEMBL7042373

SCHEMBL7042373

COc1c(Cl)cc(Cl)cc1NN

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP2D6 P10635 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 1/20 0.40
LMNA P02545 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CYP2C19 P33261 1/20 0.38
HPGD P15428 2/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HTR6 P50406 1/20 0.36
ACLY P53396 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046840 0.82 SCN4A (0.39) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL7042377 0.81 CA2 (0.39) ALDH1A1KDM4EGAAKMT2AMEN1
Hydrochloric Acid SCHEMBL15561625 0.79 GAA (0.34) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL54507 0.78 KMT2A (0.47) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL7040066 0.74 CYP3A4 (0.40) ALDH1A1KDM4EGAAKMT2AMEN1
Benzene SCHEMBL29202175 0.73 KMT2A (0.50) ALDH1A1KDM4EGAAKMT2AMEN1
Ethylene SCHEMBL28106925 0.73 KMT2A (0.44) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL9117129 0.73 MEN1 (0.45) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL30261672 0.72 GAA (0.43) ALDH1A1KDM4EGAAKMT2AMEN1
SCHEMBL6079187 0.72 GAA (0.43) ALDH1A1KDM4EGAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613786-B2 Treating urinary incontinence, asthma, irritable bowel syndrome or male erectile dysfunction BRISTOL-MYERS SQUIBB COMPANY 2003-09-02 US disclosed
US-20030144333-A1 Thiophenyl triazol-3-one derivatives as smooth muscle relaxants HEWAWASAM PIYASENA (US) 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144333-A1 Thiophenyl triazol-3-one derivatives as smooth muscle relaxants PDE3A, ADRB2, ADRB3 ALDH1A1 1237/4885KDM4E 1943/4885GAA 4519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.